These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 35652560)
1. DNA damage repair gene germline profiling for metastatic prostate cancer patients of different ancestries. Abdi B; Basset N; Perrot E; Benderra MA; Khalil A; Oudard S; Blanchet P; Brureau L; Coulet F; Cussenot O; Cancel-Tassin G Prostate; 2022 Sep; 82(12):1196-1201. PubMed ID: 35652560 [TBL] [Abstract][Full Text] [Related]
2. A systematic review of the prevalence of DNA damage response gene mutations in prostate cancer. Lang SH; Swift SL; White H; Misso K; Kleijnen J; Quek RGW Int J Oncol; 2019 Sep; 55(3):597-616. PubMed ID: 31322208 [TBL] [Abstract][Full Text] [Related]
3. PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer. Castro E; Romero-Laorden N; Del Pozo A; Lozano R; Medina A; Puente J; Piulats JM; Lorente D; Saez MI; Morales-Barrera R; Gonzalez-Billalabeitia E; Cendón Y; García-Carbonero I; Borrega P; Mendez Vidal MJ; Montesa A; Nombela P; Fernández-Parra E; Gonzalez Del Alba A; Villa-Guzmán JC; Ibáñez K; Rodriguez-Vida A; Magraner-Pardo L; Perez-Valderrama B; Vallespín E; Gallardo E; Vazquez S; Pritchard CC; Lapunzina P; Olmos D J Clin Oncol; 2019 Feb; 37(6):490-503. PubMed ID: 30625039 [TBL] [Abstract][Full Text] [Related]
4. Commentary on: "Inherited DNA-repair gene mutations in men with metastatic prostate cancer." Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS. N Engl J Med. 2016 Aug 4;375(5):443-53. Lee BH Urol Oncol; 2017 Sep; 35(9):575-576. PubMed ID: 28789927 [TBL] [Abstract][Full Text] [Related]
5. [Impact of germline BRCA2 and CHEK2 mutations on time to castration resistance in patients with metastatic hormone-nave prostate cancer]. Matveev VB; Kirichek AA; Filippova MG; Savinkova AV; Khalmurzaev OA; Lyubchenko LN Urologiia; 2019 Dec; (5):79-85. PubMed ID: 31808637 [TBL] [Abstract][Full Text] [Related]
6. Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer. Darst BF; Dadaev T; Saunders E; Sheng X; Wan P; Pooler L; Xia LY; Chanock S; Berndt SI; Gapstur SM; Stevens V; Albanes D; Weinstein SJ; Gnanapragasam V; Giles GG; Nguyen-Dumont T; Milne RL; Pomerantz M; Schmidt JA; Mucci L; Catalona WJ; Hetrick KN; Doheny KF; MacInnis RJ; Southey MC; Eeles RA; Wiklund F; Kote-Jarai Z; Conti DV; Haiman CA J Natl Cancer Inst; 2021 May; 113(5):616-625. PubMed ID: 32853339 [TBL] [Abstract][Full Text] [Related]
7. Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry. White JA; Kaninjing ET; Adeniji KA; Jibrin P; Obafunwa JO; Ogo CN; Mohammed F; Popoola A; Fatiregun OA; Oluwole OP; Karanam B; Elhussin I; Ambs S; Tang W; Davis M; Polak P; Campbell MJ; Brignole KR; Rotimi SO; Dean-Colomb W; Odedina FT; Martin DN; Yates C Cancer Res Commun; 2022 Sep; 2(9):1005-1016. PubMed ID: 36922933 [TBL] [Abstract][Full Text] [Related]
8. Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide. Antonarakis ES; Lu C; Luber B; Liang C; Wang H; Chen Y; Silberstein JL; Piana D; Lai Z; Chen Y; Isaacs WB; Luo J Eur Urol; 2018 Aug; 74(2):218-225. PubMed ID: 29439820 [TBL] [Abstract][Full Text] [Related]
9. Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death. Na R; Zheng SL; Han M; Yu H; Jiang D; Shah S; Ewing CM; Zhang L; Novakovic K; Petkewicz J; Gulukota K; Helseth DL; Quinn M; Humphries E; Wiley KE; Isaacs SD; Wu Y; Liu X; Zhang N; Wang CH; Khandekar J; Hulick PJ; Shevrin DH; Cooney KA; Shen Z; Partin AW; Carter HB; Carducci MA; Eisenberger MA; Denmeade SR; McGuire M; Walsh PC; Helfand BT; Brendler CB; Ding Q; Xu J; Isaacs WB Eur Urol; 2017 May; 71(5):740-747. PubMed ID: 27989354 [TBL] [Abstract][Full Text] [Related]
10. Characteristics of BRCA2 Mutated Prostate Cancer at Presentation. Han H; Park CK; Cho NH; Lee J; Jang WS; Ham WS; Choi YD; Cho KS Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362213 [TBL] [Abstract][Full Text] [Related]
17. A first Japanese case of neuroendocrine prostate cancer accompanied by lung and brain metastasis with somatic and germline BRCA2 mutation. Kosaka T; Hongo H; Aimono E; Matsumoto K; Hayashida T; Mikami S; Nishihara H; Oya M Pathol Int; 2019 Dec; 69(12):715-720. PubMed ID: 31631483 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of comprehensive DNA damage repair gene germline mutations in Chinese prostate cancer patients. Wu J; Wei Y; Pan J; Jin S; Gu W; Gan H; Zhu Y; Ye DW Int J Cancer; 2021 Feb; 148(3):673-681. PubMed ID: 33006389 [TBL] [Abstract][Full Text] [Related]
19. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer. Isaacsson Velho P; Silberstein JL; Markowski MC; Luo J; Lotan TL; Isaacs WB; Antonarakis ES Prostate; 2018 Apr; 78(5):401-407. PubMed ID: 29368341 [TBL] [Abstract][Full Text] [Related]
20. Commentary on "Inherited DNA-repair gene mutations in men with metastatic prostate cancer". Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS. N Engl J Med. 2016;375(5):443-53. Freedland SJ; Aronson WJ Urol Oncol; 2017 Aug; 35(8):536-537. PubMed ID: 28623070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]